IAS 2013: Male Circumcision Using the Shang Ring [VIDEO]
- Details
- Category: HIV Prevention
- Published on Wednesday, 24 July 2013 00:00
- Written by Gregory Fowler
A novel device used in the scale-up of voluntary male circumcision for HIV prevention can cut the time of the procedure in half and was associated with few side effects, but healing may be slower, according to a report presented at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this month in Kuala Lumpur.
IAS 2013: PrEP Appears Safe for Use in Conception, But May Not Be Necessary
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Friday, 19 July 2013 00:00
- Written by Roger Pebody
HIV negative women who wish to become pregnant with their male HIV positive partner can be reassured that pre-exposure prophylaxis (PrEP) appears to be a safe option in terms of maternal and infant outcomes, according to data presented at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this month in Kuala Lumpur. But modeling work suggested that if the woman’s partner is already taking HIV treatment and unprotected sex is limited to her fertile days, then the addition of PrEP may not afford any extra benefit.
IAS 2013: Scientists and Clinicians Must Challenge HIV-related Stigma
- Details
- Category: HIV Law & Criminalization
- Published on Friday, 19 July 2013 00:00
- Written by Edwin J Bernard
Scientists should not only create knowledge to improve the HIV epidemic, they also have a duty to speak out about human rights abuses and ensure that access to effective, high quality HIV prevention, care, and treatment programs are unimpeded by laws, stigma, and discrimination, experts in human rights and law asserted at several sessions held during the 
7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this month in Kuala Lumpur.
IAS 2013: Fem-PrEP Trial May Have Failed Because Participants Used Testing as Prevention
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Friday, 19 July 2013 00:00
- Written by Gus Cairns
While the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) featured news from 2 trials of pre-exposure prophylaxis (PrEP) that had positive results, it also featured an analysis of the reasons why another trial may have had a negative one.
IAS 2013: HIV/HCV Coinfected People Do Well on HCV Triple Therapy Despite Contraindications
- Details
- Category: HIV/HCV Coinfection
- Published on Friday, 19 July 2013 00:00
- Written by Liz Highleyman
Nearly three-quarters of HIV/HCV coinfected patients in the French HEPAVIH cohort achieved end-of-treatment virological response to hepatitis C treatment with telaprevir plus pegylated interferon/ribavirin, even though one-third had potential contraindications to this type of therapy, according to a report at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this month in Kuala Lumpur.
Web Design and Development by